glp-1 adoption GLP-1s in 2025: Who's Using Them, Who's Covering Them, and What's Next US households with GLP-1 users

In 2022, Eli Lilly secured FDA approval of tirzepatide, its GLP-1 drug, to treat diabetes

Do not use the pen if the liquid appears cloudy, discoloured, or contains visible particles

Over time, if we consistently reach for that evening drink, our body might start relying on it to initiate sleep

Kendall DM, Riddle MC, Rosenstock J, et al

GLP-1s (full name: glucagon-like peptide-1 receptor agonists, or GLP-1 agonists) help the pancreas release insulin, reduce blood sugar, slow the rate of stomach emptying, and increase feelings of fullness, explains Gretchen Zimmermann, RD, a registered dietitian specializing in obesity and vice president of clinical strategy at Vida Health